As the COVID-19 pandemic began to wreak havoc on the world in 2020, the biopharmaceutical industry started working tirelessly to develop a vaccine to stop this global threat. Emerging from this effort ...
STOCKHOLM--(BUSINESS WIRE)--At the mRNA Health conference in Berlin, enginzyme and AGC Inc. presented a scalable process to produce a key mRNA vaccine and therapy ingredient, N1-methylpseudouridine-5' ...
Just a few years ago, during the COVID-19 pandemic, messenger RNA (mRNA) vaccines emerged as the most effective response to viral variants. For mRNA to be used as a vaccine or therapeutic, the 'lipid ...
In addition to COVID-19, viral diseases that are driving the development of mRNA-based vaccines range from influenza to genital herpes. These vaccines are forthcoming because mRNA development ...
From this, several steps are required to create the mature mRNA. This process is essential for the cell to build new proteins," says biochemist Professor Elmar Wahle from MLU who led the team ...
Some genetic mutations that are expected to completely stop a gene from working surprisingly cause only mild or even no symptoms. Researchers in previous studies have discovered one reason why: cells ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results